C-reactive protein flare: a promising prognostic predictor for patients with hepatocellular carcinoma treated with TACE combined with lenvatinib and immune checkpoint inhibitors
PurposeTo assess the prognostic value of C-reactive protein (CRP) kinetics in patients with hepatocellular carcinoma (HCC) treated with transarterial chemoembolisation (TACE) combined with lenvatinib (LEN) and immune checkpoint inhibitors (ICIs).Method…